EBS - Monkeypox plays are lower as WHO rules out emergency status

The companies focused on solutions to contain the monkeypox virus are trading sharply lower in the pre-market Monday after the World Health Organization (WHO) said that the current outbreak did not amount to a global public health emergency. The designation specifically known as a Public Health Emergency of International Concern (PHEIC), is WHO’s highest level of warning previously issued for COVID-19 pandemic and Ebola. After a meeting of its Emergency Committee on Thursday, the WHO announced that the outbreak at this stage should not be classified as a PHEIC. However, the experts noted the need for close monitoring and review to see if there are significant changes that would warrant a reconsideration of their advice In reaction, the developers of monkeypox therapeutics such as GeoVax Labs (GOVX), SIGA Technologies (NASDAQ:SIGA) and Tonix Pharmaceuticals (TNXP) have dropped sharply in the early trading. Vaccine developers for monkeypox, Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), Emergent

For further details see:

Monkeypox plays are lower as WHO rules out emergency status